LivaNova PLC (LIVN) Financial Ratios
31 years of historical data (1995–2025) · Healthcare · Medical - Devices
EV/EBITDA
↓
14.34
↓-55% vs avg
5yr avg: 31.89
30Y Low13.2·High67.0
P/FCF
↓
20.92
↓-55% vs avg
5yr avg: 46.82
30Y Low18.6·High70.2
P/B Ratio
↓
3.01
+18% vs avg
5yr avg: 2.56
30Y Low1.3·High3.4
ROE
↓
-19.2%
↑-209% vs avg
5yr avg: -6.2%
30Y Low-240%·High58%
Debt/EBITDA
↓
1.96
↓-41% vs avg
5yr avg: 3.33
30Y Low0.0·High4.3
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
LIVN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
LivaNova PLC currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 20.9x P/FCF, 55% below the 5-year average of 46.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.6B | $3.4B | $2.5B | $2.8B | $3.0B | $4.4B | $3.2B | $3.6B | $4.4B | $3.9B | $2.2B |
| Enterprise Value | $3.5B | $3.2B | $2.8B | $3.2B | $3.3B | $4.5B | $3.7B | $4.0B | $4.6B | $3.9B | $2.3B |
| P/E Ratio → | -14.89 | — | 39.92 | 161.69 | — | — | — | — | — | — | — |
| P/S Ratio | 2.61 | 2.42 | 2.02 | 2.43 | 2.91 | 4.28 | 3.44 | 3.36 | 4.01 | 3.83 | 1.81 |
| P/B Ratio | 3.01 | 2.79 | 1.91 | 2.20 | 2.46 | 3.42 | 2.90 | 2.64 | 2.95 | 2.14 | 1.29 |
| P/FCF | 20.92 | 19.36 | 18.59 | 70.24 | 68.47 | 57.44 | — | — | 53.77 | 67.76 | 41.49 |
| P/OCF | 14.25 | 13.19 | 13.81 | 37.44 | 42.51 | 43.17 | — | — | 36.81 | 42.45 | 24.38 |
P/E links to full P/E history page with 30-year chart
LIVN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
LivaNova PLC's enterprise value stands at 14.3x EBITDA, 55% below its 5-year average of 31.9x. This is roughly in line with the Healthcare sector median of 14.1x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.30 | 2.21 | 2.76 | 3.27 | 4.35 | 3.93 | 3.67 | 4.12 | 3.88 | 1.88 |
| EV / EBITDA | 14.34 | 13.22 | 15.40 | — | — | 67.04 | — | — | — | 23.68 | 63.46 |
| EV / EBIT | 17.36 | — | 18.33 | — | — | — | — | 82.09 | — | 30.47 | 63.70 |
| EV / FCF | — | 18.42 | 20.42 | 79.60 | 76.90 | 58.46 | — | — | 55.24 | 68.68 | 43.06 |
LIVN Profitability
Margins and return-on-capital ratios measuring operating efficiency
LivaNova PLC earns an operating margin of 14.4%. Operating margins have expanded from -5.9% to 14.4% over the past 3 years, signaling improving operational efficiency. A negative ROE of -19.2% indicates the company is currently destroying shareholder equity. ROIC of 11.5% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.7% | 67.7% | 69.5% | 66.9% | 69.2% | 68.2% | 63.7% | 66.8% | 66.4% | 64.4% | 58.0% |
| Operating Margin | 14.4% | 14.4% | 10.3% | -5.9% | -7.5% | -0.1% | -29.3% | -15.8% | -22.4% | 9.5% | -2.3% |
| Net Profit Margin | -17.5% | -17.5% | 5.0% | 1.5% | -8.4% | -13.1% | -37.3% | -14.5% | -17.1% | -2.5% | -5.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -19.2% | -19.2% | 4.9% | 1.4% | -6.9% | -11.3% | -28.0% | -10.9% | -11.4% | -1.4% | -3.6% |
| ROA | -9.5% | -9.5% | 2.6% | 0.7% | -3.8% | -5.9% | -14.5% | -6.4% | -7.5% | -1.0% | -2.6% |
| ROIC | 11.5% | 11.5% | 6.0% | -3.2% | -3.9% | -0.0% | -12.5% | -7.7% | -10.7% | 3.9% | -1.1% |
| ROCE | 10.2% | 10.2% | 6.1% | -3.3% | -4.4% | -0.0% | -13.7% | -8.7% | -12.0% | 4.6% | -1.3% |
LIVN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
LivaNova PLC carries a Debt/EBITDA ratio of 2.0x, which is manageable (40% below the sector average of 3.3x). The company holds a net cash position — cash of $636M exceeds total debt of $473M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.39 | 0.39 | 0.51 | 0.50 | 0.48 | 0.22 | 0.64 | 0.29 | 0.11 | 0.08 | 0.07 |
| Debt / EBITDA | 1.96 | 1.96 | 3.76 | — | — | 4.27 | — | — | — | 0.88 | 3.42 |
| Net Debt / Equity | — | -0.14 | 0.19 | 0.29 | 0.30 | 0.06 | 0.41 | 0.24 | 0.08 | 0.03 | 0.05 |
| Net Debt / EBITDA | -0.67 | -0.67 | 1.38 | — | — | 1.17 | — | — | — | 0.32 | 2.31 |
| Debt / FCF | — | -0.94 | 1.82 | 9.36 | 8.44 | 1.02 | — | — | 1.47 | 0.92 | 1.57 |
| Interest Coverage | -3.48 | -3.48 | 2.40 | -0.38 | -0.56 | -1.48 | -1.49 | 3.21 | -24.19 | 16.54 | 3.37 |
Net cash position: cash ($636M) exceeds total debt ($473M)
LIVN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.36x means LivaNova PLC can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 2.95x to 1.36x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | 1.36 | 2.87 | 2.95 | 2.98 | 0.97 | 2.29 | 1.07 | 1.07 | 2.14 | 1.96 |
| Quick Ratio | 1.16 | 1.16 | 2.50 | 2.51 | 2.54 | 0.82 | 1.92 | 0.75 | 0.76 | 1.79 | 1.38 |
| Cash Ratio | 0.79 | 0.79 | 1.09 | 0.80 | 0.72 | 0.30 | 0.82 | 0.12 | 0.10 | 0.23 | 0.13 |
| Asset Turnover | — | 0.53 | 0.50 | 0.47 | 0.45 | 0.47 | 0.39 | 0.45 | 0.43 | 0.40 | 0.52 |
| Inventory Turnover | 2.72 | 2.72 | 2.59 | 2.59 | 2.43 | 3.11 | 2.94 | 2.20 | 2.43 | 2.50 | 2.78 |
| Days Sales Outstanding | — | 56.80 | 65.14 | 68.05 | 76.74 | 78.61 | 72.34 | 86.98 | 84.44 | 103.20 | 64.12 |
LIVN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
LivaNova PLC returns 0.1% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 2.5% | 0.6% | — | — | — | — | — | — | — |
| FCF Yield | 4.8% | 5.2% | 5.4% | 1.4% | 1.5% | 1.7% | — | — | 1.9% | 1.5% | 2.4% |
| Buyback Yield | 0.1% | 0.1% | 0.3% | 0.3% | 0.3% | 0.0% | 0.2% | 0.2% | 1.4% | 0.1% | 2.5% |
| Total Shareholder Yield | 0.1% | 0.1% | 0.3% | 0.3% | 0.3% | 0.0% | 0.2% | 0.2% | 1.4% | 0.1% | 2.5% |
| Shares Outstanding | — | $55M | $55M | $54M | $54M | $51M | $49M | $48M | $48M | $49M | $49M |
Peer Comparison
Compare LIVN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 LIVNYou | $4B | -14.9 | 14.3 | 20.9 | 67.7% | 14.4% | -19.2% | 11.5% | 2.0 |
 NVCR | $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.8 | 8.0 | 9.8 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 GKOS | $8B | -41.2 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 MDT | $99B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ABT | $150B | 11.3 | 15.7 | 23.6 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $83B | 28.9 | 25.1 | 22.8 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SYK | $112B | 34.8 | 20.2 | 26.1 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 ELMD | $215M | 30.2 | 18.4 | 19.4 | 78.1% | 15.1% | 17.2% | 25.6% | 0.0 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 ISRG | $160B | 57.4 | 43.4 | 64.4 | 66.0% | 29.3% | 16.6% | 15.0% | 0.1 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 30 years · Updated daily
See LIVN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LIVN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LIVN vs NVCR
Side-by-side business, growth, and profitability comparison vs NovoCure Limited.
Start ComparisonLIVN — Frequently Asked Questions
Quick answers to the most common questions about buying LIVN stock.
What is LivaNova PLC's P/E ratio?
LivaNova PLC's current P/E ratio is -14.9x. The historical average is 100.8x.
What is LivaNova PLC's EV/EBITDA?
LivaNova PLC's current EV/EBITDA is 14.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 36.6x.
What is LivaNova PLC's ROE?
LivaNova PLC's return on equity (ROE) is -19.2%. The historical average is -18.7%.
Is LIVN stock overvalued?
Based on historical data, LivaNova PLC is trading at a P/E of -14.9x. Compare with industry peers and growth rates for a complete picture.
What are LivaNova PLC's profit margins?
LivaNova PLC has 67.7% gross margin and 14.4% operating margin. Operating margin between 10-20% is typical for established companies.
How much debt does LivaNova PLC have?
LivaNova PLC's Debt/EBITDA ratio is 2.0x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.